Company / PP&E (Net)
Apogee Therapeutics, Inc. PP&E (Net) History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.0M
FY2024
5-year range
$377.0K / $2.0M
FY2023-FY2024
Trend
+419.6%
vs FY2023
Sector context
#135 of 193
Health Care
What the data says
At $2M, Apogee Therapeutics, Inc.'s pp&e (net) ranks #135 of 193 in the Health Care sector.
Based on SEC 10-K filings.
$2M in FY2024.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#135 of 193 in Health CareTop 70% of 193This company $2.0M Sector average $777.6M
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2024, pp&e (net) increased 419.6% year-over-year.
- Ranks #135 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.0M | +419.6% |
| FY2023 | $377.0K | - |
| FY2022 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026